Prognostic impact of highly active antiretroviral therapy in HIV-related Hodgkin's disease

This publication has 13 references indexed in Scilit:

• Favorable Impact of Virological Response to Highly Active Antiretroviral Therapy on Survival in Patients with AIDS-related Lymphoma
  Leukemia & Lymphoma, 2002
• Hodgkin disease developing in patients infected by human immunodeficiency virus results in clinical features and a prognosis similar to those in patients with human immunodeficiency virus-related non-Hodgkin lymphoma
  Cancer, 2001
• Survival of AIDS patients with primary central nervous system lymphoma is dramatically improved by HAART-induced immune recovery
  AIDS, 2001
• Better response to chemotherapy and prolonged survival in AIDS-related lymphomas responding to highly active antiretroviral therapy
  AIDS, 2001
• Impact of HAART on the clinical management of AIDS-related cancers
  European Journal Of Cancer, 2001
• Association of Cancer With AIDS-Related Immunosuppression in Adults
  JAMA, 2001
• Influence of highly active anti‐retroviral therapy on response to treatment and survival in patients with acquired immunodeficiency syndrome‐related non‐Hodgkin's lymphoma treated with cyclophosphamide, hydroxydoxorubicin, vincristine and prednisone
  British Journal of Haematology, 2001
• Concomitant cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy plus highly active antiretroviral therapy in patients with human immunodeficiency virus-related, non-Hodgkin lymphoma
  Cancer, 2001
• HIV-associated non-Hodgkin‚s lymphoma: highly active antiretroviral therapy improves remission rate of chemotherapy
  AIDS, 1999
• Hodgkin's disease and human immunodeficiency virus infection: clinicopathologic and virologic features of 114 patients from the Italian Cooperative Group on AIDS and Tumors.
  Journal of Clinical Oncology, 1995